News for Cerevel Therapeutics Holdings Inc Stock (CERE)

AbbVie Completes Acquisition of Cerevel Therapeutics

PRNewsWire • 08/01/24

The Schall Law Firm Is Performing A Scrutiny Into Cerevel Therapeutics Holdings Inc And Proprietors Of CERE Shares Are Welcomed To Engage

Accesswire • 07/01/24

The Schall Law Firm Is Carrying Out An Inquiry Into Cerevel Therapeutics Holdings Inc And Possessors Of CERE Shares Are Requested To Be Part Of It

Accesswire • 06/30/24

The Schall Law Firm Is Undertaking An Investigation Into Cerevel Therapeutics Holdings Inc And Holders Of CERE Shares Are Encouraged To Participate

Accesswire • 06/29/24

The Schall Law Firm Is Undertaking An Investigation Into Cerevel Therapeutics Holdings Inc And Holders Of CERE Stocks Are Encouraged To Participate

Accesswire • 06/28/24

The Schall Law Firm Is Conducting A Probe Into Cerevel Therapeutics Holdings Inc And Shareholders Of CERE Are Invited To Join

Accesswire • 06/27/24

The Schall Law Firm Is Conducting A Probe Into Cerevel Therapeutics Holdings Inc And Owners Of CERE Shares Are Invited To Join

Accesswire • 06/26/24

CEREVEL (NASDAQ:CERE) ACQUISITION ALERT: Cerevel's $45 Per Share Deal is Being Investigated by BFA Law, Shareholders are Notified to Contact the Firm

Accesswire • 06/25/24

The Schall Law Firm Is Embarking On A Probe Into Cerevel Therapeutics Holdings Inc And CERE Shareholders Are Invited To Join

Accesswire • 06/25/24

CEREVEL (NASDAQ:CERE) STOCK ALERT: Cerevel's $45 Per Share Deal is Being Investigated by BFA Law, Shareholders are Urged to Contact the Firm

GlobeNewsWire • 06/25/24

The Schall Law Firm Is Undertaking An Investigation Into Cerevel Therapeutics Holdings Inc And Shareholders Of CERE Can Participate

Accesswire • 06/24/24

CEREVEL (NASDAQ:CERE) INVESTOR UPDATE: Cerevel's $45 Per Share Offer is Being Investigated by BFA Law, Shareholders are Urged to Contact the Firm

Accesswire • 06/24/24

An Investigation Into Cerevel Therapeutics Holdings Inc Is Being Undertaken By The Schall Law Firm And Shareholders Of CERE Can Join

Accesswire • 06/23/24

The Schall Law Firm Is Leading An Investigation Into Cerevel Therapeutics Holdings Inc And CERE Shareholders Are Invited To Be Involved

Accesswire • 06/22/24

CEREVEL (NASDAQ:CERE) INVESTOR ALERT: Cerevel's $45 Per Share Offer is Being Investigated by BFA Law, Shareholders are Encouraged to Contact the Firm

GlobeNewsWire • 06/22/24

CEREVEL INVESTOR NOTICE: Cerevel's (NYSE:CERE) $45 Per Share Offer is Being Investigated by BFA Law, Shareholders are Reminded to Contact the Firm

Accesswire • 06/21/24

CERE Shareholders Can Participate In The Cerevel Therapeutics Holdings Inc Probe Led By The Schall Law Firm

Accesswire • 06/21/24

CEREVEL SHAREHOLDER ALERT: Is $45 Per Share Enough for Cerevel (NYSE:CERE)? Contact BFA Law about its Ongoing Review into the Offer

Accesswire • 06/20/24

Shareholders Of CERE Have The Opportunity To Be Involved In The Investigation Of Cerevel Therapeutics Holdings Inc Directed By The Schall Law Firm

Accesswire • 06/20/24

CERE Investors Have the Opportunity to Join Investigation of Cerevel Therapeutics Holdings, Inc. with the Schall Law Firm

PRNewsWire • 06/20/24

CEREVEL INVESTOR REMINDER: Think $45 Per Share is Too Low for Cerevel (Nasdaq:CERE)? Contact BFA Law about Continuing Investigation into the Offer

GlobeNewsWire • 06/20/24

CEREVEL INVESTIGATION REMINDER: Think $45 Per Share is Too Low for Cerevel (NYSE:CERE)? Contact BFA Law about Ongoing Investigation into the Offer

Accesswire • 06/19/24

Investors Of CERE Can Participate In The Probe Of Cerevel Therapeutics Holdings Inc Led By The Schall Law Firm

Accesswire • 06/19/24

CEREVEL STOCK INQUIRY: Is $45 Per Share Enough for Cerevel (CERE)? Contact BFA Law about Ongoing Investigation into the Deal Price

Accesswire • 06/18/24

CEREVEL STOCK UPDATE: Is $45 Per Share Enough for Cerevel (Nasdaq:CERE)? Contact BFA Law about Ongoing Investigation into the Deal Price

GlobeNewsWire • 06/18/24